NU Skin Enterprises Inc (NUS) FinancialsNUSNU Skin Enterprises Inc

Nu Skin Enterprises, Inc. (NUS) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Nu Skin, accounting for 83.1% of total sales, equivalent to $320.90M. Other significant revenue streams include Manufacturing and Rhyz other. Understanding this composition is critical for investors evaluating how NUS navigates market cycles within the Personal Products industry.

Evaluating the bottom line, Nu Skin Enterprises, Inc. maintains a gross margin of 68.20%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 6.11%, while the net margin is -78.03%. These profitability ratios, combined with a Return on Equity (ROE) of -32.53%, provide a clear picture of how effectively NUS converts its operational activities into shareholder value.

In the context of the broader market, NUS competes directly with industry leaders such as YSG and SLSN. With a market capitalization of $242.91M, it holds a leading position in the sector. When comparing efficiency, NUS's gross margin of 68.20% stands against YSG's 73.88% and SLSN's 30.97%. Such benchmarking helps identify whether Nu Skin Enterprises, Inc. is trading at a premium or discount relative to its financial performance.

The company's recent financial performance shows fluctuations, with a gross margin of 68.20% in Q2 2026, which is relatively strong, but a concerning net income of -249798000.00 USD in the same quarter. The forward P/E ratio of 4.008 suggests that the stock may be undervalued based on future earnings expectations.